BioSpace News Archive

Business

Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018

Aethlon Medical today announced it will issue third quarter results for the fiscal year ended March 31, 2018 at 4:15 pm eastern time on Thursday, February 1, 2018.

January 29, 2018
·
2 min read
Pharm Country

Data Highlighting Advaxis’ Antigen Delivery Platform Accepted for Multiple Presentations at 2018 Keystone Symposia Conference on Cancer Immunotherapies

Advaxis announces that three abstracts highlighting the Company’s Listeria-based immunotherapy in combination with antibody-based immunotherapies have been accepted for poster presentation at the upcoming 2018 Keystone Symposia on Cancer Immunotherapies: Combinations (C5) taking place March 23-27, 2018 at the Queen Elizabeth Fairmont in Montreal.

January 29, 2018
·
3 min read
Drug Development

Ensysce Biosciences Inc. Receives Fast Track Designation for PF614, BIO-MD Abuse Deterrent Extended Release Oxycodone Prodrug

Ensysce Biosciences Inc. is pleased to announce that the FDA has granted Fast Track designation for the development of PF614 for management of moderate to severe chronic pain when a continuous, around-the-clock analgesic is needed for an extended period of time.

January 29, 2018
·
2 min read
LimFlow Completes Enrollment In U.S. Feasibility Study and Receives Breakthrough Device Status from FDA for Its Percutaneous Deep Vein Arterialization (pDVA) System

LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), today announced completion of enrollment of the original 10-patient cohort in the U.S. feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System.

January 29, 2018
·
3 min read
Business

Viemed Announces 2017 Year End Preliminary Financial Results

Viemed announced today that it expects to post final year end December 31, 2017 results on SEDAR by the end of March after the completion of the independent audit.

January 29, 2018
·
7 min read
BioMidwest

Sun Biopharma Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer

It is anticipated that the first patient will be enrolled in early Q2 2018.

January 29, 2018
·
5 min read
Drug Development

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa

EB-101 is the Company’s gene-corrected autologous cell therapy product for patients with recessive dystrophic epidermolysis bullosa.

January 29, 2018
·
6 min read
Business

Ultragenyx Names Former Alexion Exec as New CMO

Most recently, Dr. Bedrosian was Senior Vice President and Chief Medical Officer at Alexion.

January 29, 2018
·
3 min read
Biotech Bay

Adamas Announces Closing of Its Public Offering of Common Stock, and Full Exercise of Underwriters’ Option to Purchase Additional Shares

The purchase of the 3,000,000 shares closed on January 26, 2018. The sale of the 450,000 shares is expected to close on January 30, 2018, subject to customary closing conditions.

January 29, 2018
·
2 min read
Deals

Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors From Japan Tobacco

The portfolio includes compounds covered by five separate patent applications, together with several new unpatented chemical series.

January 29, 2018
·
1 min read